Detalles de la búsqueda
1.
Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.
Acta Pharmacol Sin
; 42(11): 1875-1887, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33608672
2.
Author Correction: Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.
Acta Pharmacol Sin
; 43(7): 1881, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34873318
Resultados
1 -
2
de 2
1
Próxima >
>>